Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
Chang-Hoon LeeMi-Sook KimSee-Hwee YeoChin-Kook RheeHeung-Woo ParkBo-Ram YangJoongyub LeeEun-Yeong ChoXiaomeng XuAldo Amador Navarro RojasSumitra ShantakumarDominique MileaNam Kyong ChoiPublished in: Respiratory research (2022)
Patients with COPD in South Korea experienced frequent exacerbations prior to MITT, and PDC by MITT was low. Patients may benefit from early optimization of COPD therapy, and greater emphasis on adherence to inhaled COPD therapy. Severe exacerbations were found to incur substantial costs; treatment alternatives that can reduce the rate of severe exacerbations are likely to minimize healthcare costs.
Keyphrases
- chronic obstructive pulmonary disease
- cystic fibrosis
- lung function
- healthcare
- end stage renal disease
- newly diagnosed
- early onset
- chronic kidney disease
- ejection fraction
- prognostic factors
- type diabetes
- adipose tissue
- mesenchymal stem cells
- combination therapy
- skeletal muscle
- air pollution
- replacement therapy
- patient reported outcomes
- health insurance
- insulin resistance
- affordable care act